Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $120.38 billion. The enterprise value is $135.58 billion.
Important Dates
The last earnings date was Friday, October 24, 2025, before market open.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
Sanofi has 1.22 billion shares outstanding. The number of shares has decreased by -1.65% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.22B |
| Shares Change (YoY) | -1.65% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 58.31% |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 11.26 and the forward PE ratio is 10.41.
| PE Ratio | 11.26 |
| Forward PE | 10.41 |
| PS Ratio | 2.23 |
| Forward PS | 2.54 |
| PB Ratio | 1.40 |
| P/TBV Ratio | 23.34 |
| P/FCF Ratio | 11.09 |
| P/OCF Ratio | 9.23 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 9.37, with an EV/FCF ratio of 12.49.
| EV / Earnings | 12.68 |
| EV / Sales | 2.52 |
| EV / EBITDA | 9.37 |
| EV / EBIT | 12.04 |
| EV / FCF | 12.49 |
Financial Position
The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.30.
| Current Ratio | 1.06 |
| Quick Ratio | 0.29 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.72 |
| Debt / FCF | 2.35 |
| Interest Coverage | 24.55 |
Financial Efficiency
Return on equity (ROE) is 8.84% and return on invested capital (ROIC) is 6.25%.
| Return on Equity (ROE) | 8.84% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.25% |
| Return on Capital Employed (ROCE) | 9.83% |
| Revenue Per Employee | $650,241 |
| Profits Per Employee | $129,012 |
| Employee Count | 82,878 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Sanofi has paid $1.80 billion in taxes.
| Income Tax | 1.80B |
| Effective Tax Rate | 19.14% |
Stock Price Statistics
The stock price has decreased by -3.12% in the last 52 weeks. The beta is 0.44, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | -3.12% |
| 50-Day Moving Average | 48.64 |
| 200-Day Moving Average | 51.02 |
| Relative Strength Index (RSI) | 50.43 |
| Average Volume (20 Days) | 2,497,283 |
Short Selling Information
The latest short interest is 4.81 million, so 0.39% of the outstanding shares have been sold short.
| Short Interest | 4.81M |
| Short Previous Month | 4.11M |
| Short % of Shares Out | 0.39% |
| Short % of Float | 0.44% |
| Short Ratio (days to cover) | 1.31 |
Income Statement
In the last 12 months, Sanofi had revenue of $53.89 billion and earned $10.69 billion in profits. Earnings per share was $8.67.
| Revenue | 53.89B |
| Gross Profit | 38.80B |
| Operating Income | 11.26B |
| Pretax Income | 9.39B |
| Net Income | 10.69B |
| EBITDA | 14.47B |
| EBIT | 11.26B |
| Earnings Per Share (EPS) | $8.67 |
Full Income StatementBalance Sheet
The company has $10.45 billion in cash and $25.53 billion in debt, giving a net cash position of -$15.08 billion or -$12.38 per share.
| Cash & Cash Equivalents | 10.45B |
| Total Debt | 25.53B |
| Net Cash | -15.08B |
| Net Cash Per Share | -$12.38 |
| Equity (Book Value) | 86.28B |
| Book Value Per Share | 70.57 |
| Working Capital | 2.27B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $13.04 billion and capital expenditures -$2.03 billion, giving a free cash flow of $10.86 billion.
| Operating Cash Flow | 13.04B |
| Capital Expenditures | -2.03B |
| Free Cash Flow | 10.86B |
| FCF Per Share | $8.91 |
Full Cash Flow StatementMargins
Gross margin is 72.00%, with operating and profit margins of 20.90% and 19.84%.
| Gross Margin | 72.00% |
| Operating Margin | 20.90% |
| Pretax Margin | 17.43% |
| Profit Margin | 19.84% |
| EBITDA Margin | 26.85% |
| EBIT Margin | 20.90% |
| FCF Margin | 20.14% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 3.22%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 3.22% |
| Dividend Growth (YoY) | 8.13% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 18.43% |
| Buyback Yield | 1.65% |
| Shareholder Yield | 4.87% |
| Earnings Yield | 8.88% |
| FCF Yield | 9.02% |
Dividend DetailsAnalyst Forecast
The average price target for Sanofi is $61.50, which is 23.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $61.50 |
| Price Target Difference | 23.84% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 4.84% |
| EPS Growth Forecast (5Y) | 19.21% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
